Scientists probe hidden heart risks of breast cancer drugs
NCT ID NCT06781762
Summary
This study aims to understand how a common breast cancer hormone therapy affects heart and blood vessel health in the first six months of treatment. Researchers will compare 40 breast cancer patients starting this therapy to a similar group without cancer, measuring various heart and metabolic health markers. The goal is to identify early signs of cardiovascular side effects to improve patient monitoring and care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Toronto
RECRUITINGToronto, Ontario, M5S2C9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.